How I Treat Acute and Persistent Sickle Cell Pain

被引:7
|
作者
Ballas, Samir K. [1 ]
机构
[1] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Sidney Kimmel Med Coll, Dept Med, Philadelphia, PA 19107 USA
关键词
Sickle cell disease; Sickle cell anemia; Pain; Vaso-occlusive crisis; MAINTENANCE TREATMENT; SELF-MANAGEMENT; DISEASE; MORPHINE; TOLERANCE; LOFEXIDINE; ANEMIA; HYPERALGESIA; FREQUENCY; METHADONE;
D O I
10.4084/MJHID.2020.064
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sickle pain is the hallmark of sickle cell disease (SCD). It could be acute, persistent/relapsing, chronic, or neuropathic. Although there is a general consensus that pain is a major manifestation of SCD, there is a controversy as to the types of pain and their interrelationship between acute, chronic, relapsing, persistent, etc. This report first reviews the general approach to the management of acute vaso-occlusive crisis (VOC) pain, including education, counseling, pharmacotherapy, non-pharmacotherapy, and fluid therapy. This is followed by the presentation of five patients that represent typical issues that are commonly encountered in the management of patients with SCD. These issues are: individualized treatment of pain, bilaterality of pain, use of illicit drugs, tolerance to opioids, opioid-induced hyperalgesia, and withdrawal syndrome. The clinical aspects and management of each of these issues are described. Moreover, such complications as tolerance and withdrawal may persist after discharge and may be mistaken as chronic pain rather than resolving, persistent or relapsing pain.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Pain Syndromes in Sickle Cell Disease: An Update
    Niscola, Pasquale
    Sorrentino, Francesco
    Scaramucci, Laura
    de Fabritiis, Paolo
    Cianciulli, Paolo
    PAIN MEDICINE, 2009, 10 (03) : 470 - 480
  • [32] Clinically significant differences in the visual analog pain scale in acute vasoocclusive sickle cell crisis
    Lopez, Bernard L.
    Flenders, Pamela
    Davis-Moon, Linda
    Corbin, Theodore
    Ballas, Samir K.
    HEMOGLOBIN, 2007, 31 (04) : 427 - 432
  • [33] New era dawns on sickle cell pain
    Ballas, Samir K.
    BLOOD, 2010, 116 (03) : 311 - 312
  • [34] Emergency department management of acute pain episodes in sickle cell disease
    Tanabe, Paula
    Myers, Randall
    Zosel, Amy
    Brice, Jane
    Ansari, Altaf H.
    Evans, Julia
    Martinovich, Zoran
    Todd, Knox H.
    Paice, Judith A.
    ACADEMIC EMERGENCY MEDICINE, 2007, 14 (05) : 419 - 425
  • [35] How should I treat acute valve regurgitation?
    Schultz, Carl
    Piazza, Nicolo
    Weustink, Annick
    Ligthart, Jurgen
    Otten, Amber
    de Jaegere, Peter
    Serruys, Patrick W.
    EUROINTERVENTION, 2011, 7 (01) : 151 - 159
  • [36] The management of sickle cell pain
    Richard, Robert E.
    CURRENT PAIN AND HEADACHE REPORTS, 2009, 13 (04) : 295 - 297
  • [37] Stigma and Pain in Adolescents Hospitalized for Sickle Cell Vasoocclusive Pain Episodes
    Martin, Sarah R.
    Cohen, Lindsey L.
    Mougianis, Ifigenia
    Griffin, Anya
    Sil, Soumitri
    Dampier, Carlton
    CLINICAL JOURNAL OF PAIN, 2018, 34 (05) : 438 - 444
  • [38] Can we use biomarkers to identify those at risk of acute pain from sickle cell disease?
    Bhat, Varsha
    Sheehan, Vivien A.
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (08) : 411 - 418
  • [39] Evaluation of a Non-Parenteral Opioid Analgesia Protocol for Acute Sickle Cell Pain Episodes in Children
    Telfer, Paul
    Barroso, Filipa
    Newell, Kim
    Challands, Jo
    Kaya, Banu
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [40] Acute Vaso-Occlusive Pain is Temporally Associated with the Onset of Menstruation in Women with Sickle Cell Disease
    Sharma, Deva
    Day, Melissa E.
    Stimpson, Sarah-Jo
    Rodeghier, Mark
    Ghafuri, Djamila
    Callaghan, Michael
    Zaidi, Ahmar Urooj
    Hannan, Bryan
    Kassim, Adetola
    Zempsky, William
    Wellons, Melissa
    James, Andra
    Bruehl, Stephen
    DeBaun, Michael R.
    JOURNAL OF WOMENS HEALTH, 2019, 28 (02) : 162 - 169